FDAnews
www.fdanews.com/articles/192903-fda-approves-package-limits-unit-doses-for-anti-diarrhea-drug
Red_Approved_Stamp.gif

FDA Approves Package Limits, Unit Doses for Anti-Diarrhea Drug

September 30, 2019

The FDA approved new packages for OTC branded forms of the anti-diarrhea drug loperamide, limiting each carton to no more than 48 milligrams and requiring unit-dose blister packaging.

Some opioid abusers take the drug in high doses for treatment of withdrawal symptoms. In 2017, the FDA added a warning to the product’s Drug Facts panel on the risk of serious heart problems or death from using high doses.

The new packaging is for Imodium A-D, Imodium Multi-Symptom Relief and Be Health Loperamide HCl Capsules. The maximum approved dose of OTC loperamide for adults is eight milligrams per day and 16 milligrams per day for prescription use.

View today's stories